Outset Medical Reports Improved Q4 & FY25 Financials, Reduced Cash Burn, and Modest 2026 Revenue Guidance
OM sits 46% above its 52-week low of $3.1.
Summary
Outset Medical reported improved Q4 and full-year 2025 financial results, showcasing expanded gross margins and a significant reduction in cash burn, alongside modest revenue growth and 2026 guidance.
Key Events · Earnings and Guidance · OM
-
Q4 & FY2025 Revenue Performance
Full year 2025 revenue increased 5% to $119.5 million, while fourth quarter revenue slightly decreased by 2% to $28.9 million compared to the prior year.
-
Significant Gross Margin Expansion
GAAP gross margin significantly expanded to 42.4% in Q4 2025 (from 36.5% in Q4 2024) and to 39.1% for the full year 2025 (from 33.9% in 2024).
-
Reduced Operating Expenses & Improved Net Loss
Operating expenses declined 8% in Q4 and substantially for the full year 2025, contributing to an improved net loss of $19.5 million in Q4 and $81.7 million for FY2025.
-
Strong Cash Position & Reduced Cash Burn
The company ended 2025 with $173 million in cash and investments, having significantly reduced net cash used in operations to $46 million in 2025 from $116 million in 2024.
Analysis · OM · Industrial Applications And Services
Outset Medical's latest earnings report highlights significant operational improvements, including substantial gross margin expansion and a notable reduction in cash used in operations for 2025. While revenue growth remains modest, the company's strengthened cash position and disciplined expense management are critical for its long-term viability and path to profitability. Investors should monitor continued margin expansion and revenue acceleration in 2026.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 30.2% of the 1644 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.49%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, OM was trading at $4.54 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $82.3M. The 52-week trading range was $3.10 to $21.98. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.